Progress in targeting tumor cells by using drug-magnetic nanoparticles conjugate. - Publication - Bridge of Knowledge

Search

Progress in targeting tumor cells by using drug-magnetic nanoparticles conjugate.

Abstract

To limit the cytotoxicity of anticancer drugs against healthy cells, an appropriate carrier should be synthesized to deliver the drug to the tumor tissue only. A good solution is to anchor a magnetic nanoparticle to the molecule of the drug and to use a properly directed external magnetic field. We have shown that the improved by us synthesis of the conjugate of doxorubicin with iron-oxide magnetic nanoparticles allows a substantial depression of the aggregation process of the nanoparticles and therefore the examination of cytotoxicity of the modified drug. It has been shown that the use of magnetic field guarantees the efficient delivery of the drug to the desired place and an increase in the number of DOX molecules to one magnetic particles was achieved. It has also been found that the release of the drug takes place below pH 6, which characterizes the cancer cells. It has also been found that while the iron oxide magnetic nanoparticles were not cytotoxic toward human urinary bladder carcinoma cells UM-UC-3, the tumor cell sensitivity of the DOX-Np complex was slightly higher in comparison to the identical concentration of doxorubicin alone.

Authors (8)

Cite as

Full text

full text is not available in portal

Keywords

Details

Category:
Articles
Type:
artykuł w czasopiśmie wyróżnionym w JCR
Published in:
BIOMACROMOLECULES no. 14, pages 828 - 833,
ISSN: 1525-7797
Language:
English
Publication year:
2013
Bibliographic description:
Nowicka A., Kowalczyk A., Jarzębińska A., Donten M., Krysiński P., Stojek Z., Augustin E., Mazerska Z.: Progress in targeting tumor cells by using drug-magnetic nanoparticles conjugate.// BIOMACROMOLECULES. -Vol. 14, (2013), s.828-833
Verified by:
Gdańsk University of Technology

seen 95 times

Recommended for you

Meta Tags